Sanofi-Aventis to strengthen R&D in Korea

Published: 2010-01-08 06:59:00

Updated: 2010-01-08 06:59:00

Sanofi-Aventis, the world's fourth-largest pharmaceutical company, plans to support local hospitals' clinical tests, seeking joint projects to develop new drugs and helping nurture the nation's bio industry in collaboration with the Korea Health Industry Development Institute.

Last year, the Paris-based Sanofi unveiled its plan to invest 70 billion won in research and development (R&D) in Ko...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.